Home
>
National Drug Code (NDC)
>
CycloSPORINE
CycloSPORINE - 0591-2223-15 - (CycloSPORINE)
Drug Information of CycloSPORINE
| Product NDC: | 0591-2223 |
| Proprietary Name: | CycloSPORINE |
| Non Proprietary Name: | CycloSPORINE |
| Active Ingredient(s): | 100 mg/1 & nbsp; CycloSPORINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, LIQUID FILLED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CycloSPORINE
| Product NDC: | 0591-2223 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065044 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081201 |
Package Information of CycloSPORINE
| Package NDC: | 0591-2223-15 |
| Package Description: | 1 BLISTER PACK in 1 BOX (0591-2223-15) > 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
NDC Information of CycloSPORINE
| NDC Code | 0591-2223-15 |
| Proprietary Name | CycloSPORINE |
| Package Description | 1 BLISTER PACK in 1 BOX (0591-2223-15) > 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK |
| Product NDC | 0591-2223 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CycloSPORINE |
| Dosage Form Name | CAPSULE, LIQUID FILLED |
| Route Name | ORAL |
| Start Marketing Date | 20081201 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | CYCLOSPORINE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
